SUBSCRIBE
SUBSCRIBE
News   FDA

Genentech’s (JOBS) Psoriasis Drug Raptiva Gets FDA Warning

October 17, 2008 | 
1 min read
WASHINGTON, Oct 16 (Reuters) - U.S. health regulators have ordered strong black-box warnings for Genentech Inc's psoriasis drug, Raptiva, saying patients given the once-weekly injections are at risk for life-threatening infections.
FDA Approvals
Genentech, Inc. Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration
Mergers & acquisitions
Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks
June 26, 2025
 · 
4 min read
 · 
Annalee Armstrong
FDA Headquarters_Grandbrothers/Adobe Stock
Policy
Former CBER Chief Marks Decries New FDA COVID-19 Framework
June 26, 2025
 · 
3 min read
 · 
Tristan Manalac
Finding Talent. Big Hands with Magnifying Glass Recruiting People. vector
Duchenne muscular dystrophy
FDA Reviews Sarepta’s Elevidys After Second Patient Death
June 25, 2025
 · 
2 min read
 · 
Tristan Manalac
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
FDA
FDA Names Psychedelic Proponent as CDER Deputy Director, Top Spot Remains Open
June 25, 2025
 · 
2 min read
 · 
Tristan Manalac